Inge M.W. Verberk

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Shorena Janelidze, Charlotte E. Teunissen, Henrik Zetterberg et al. · JAMA Neurology · 2021 · 502 citations · Full text

Medicine, Neurology, Neuroscience +17

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

Pratishtha Chatterjee, Steve Pedrini, Erik Stoops et al. · Translational Psychiatry · 2021 · 460 citations · Full text

Medicine, Neurology, Neuroscience +17

Plasma Amyloid as Prescreener for the Earliest <scp>A</scp>lzheimer Pathological Changes

Inge M.W. Verberk, Rosalinde E.R. Slot, Sander C.J. Verfaillie et al. · Annals of Neurology · 2018 · 322 citations · Full text

Medicine, Neurology, Neuroscience +17

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn et al. · Alzheimer s Research & Therapy · 2020 · 273 citations · Full text

Medicine, Neurology, Neuroscience +17

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn et al. · Alzheimer s & Dementia · 2021 · 243 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17